AZTA

Azenta Inc
NASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

Key Statistics

Market Cap
$1.12B
P/E Ratio
41.79
EPS
$0.58
Beta
1.47
52W High
$41.73
52W Low
$19.87
50-Day MA
$24.01
200-Day MA
$30.45
Dividend Yield
Profit Margin
-10.10%
Forward P/E
29.07
PEG Ratio
0.53

About Azenta Inc

Azenta Inc. is a premier provider of sample management solutions and life science tools, dedicated to enhancing laboratory efficiencies for the biotechnology and pharmaceutical industries. By leveraging innovative automated solutions, comprehensive biorepository services, and advanced storage technologies, the company enables clients to accelerate drug discovery while adhering to stringent regulatory requirements. With a strong emphasis on cutting-edge technology and strategic partnerships, Azenta is well-positioned to seize growth opportunities in the expanding global life sciences market. Its commitment to advancing scientific research through sophisticated products further solidifies its competitive advantage in biobanking and sample management.

Official WebsiteUSAFY End: September

Fundamentals

Revenue (TTM)$595.03M
Gross Profit (TTM)$265.16M
EBITDA$37.33M
Operating Margin-4.10%
Return on Equity1.53%
Return on Assets-0.59%
Revenue/Share (TTM)$12.99
Book Value$37.26
Price-to-Book0.68
Price-to-Sales (TTM)1.88
EV/Revenue1.35
EV/EBITDA21.56
Quarterly Earnings Growth (YoY)8778.00%
Quarterly Revenue Growth (YoY)0.80%
Shares Outstanding$46.06M
Float$40.65M
% Insiders0.92%
% Institutions118.89%

Historical Volatility

HV 10-Day
57.88%
HV 20-Day
56.67%
HV 30-Day
57.01%
HV 60-Day
74.90%
HV Rank
59.1%

Volatility is currently expanding

Analyst Ratings

Consensus ($35.40 target)
2
Strong Buy
2
Buy
3
Hold
Data last updated: 4/30/2026